Merck Raises Zocor 2006 Guidance By $300 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Given the introduction of generic simvastatin, the company remains positive on sales of Zocor.
You may also be interested in...
Teva And Ranbaxy Launch Generic Zocor With 180-Day Exclusivity
Despite an eleventh-hour suit by Sandoz, FDA approved the generic companies’ ANDAs for simvastatin.
Merck Extends Shelf Life Of Branded Zocor Through Rebate Deal With UnitedHealth
Sen. Schumer demands FTC investigation over Merck's alleged "anti-competitive" actions.
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue